CH
EPIX

CVI Holdings’s ESSA Pharma EPIX Stock Holding History

CVI Holdings’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-57,338
Closed -$219K – 57
2018
Q1 		$219K Buy
+57,338
New +$239K 0.3% 28

Other funds holding EPIX

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

CVI Holdings's EPIX Position: Q2 2018 in Review

CVI Holdings sold out of ESSA Pharma (EPIX) in Q2 2018, closing a stake of 57,338 shares — an estimated $219K sold.

CVI Holdings first reported a position in EPIX in Q1 2018 and held it in 1 quarter. The position peaked at $219K in Q1 2018. 9 funds tracked by Wall St. Rank hold EPIX as of Q2 2018.

  • CVI Holdings reported no remaining ESSA Pharma position as of Q2 2018 after selling out during the quarter.
  • CVI Holdings sold 57,338 ESSA Pharma shares in Q2 2018, an estimated $219K.
  • CVI Holdings first reported a position in ESSA Pharma in Q1 2018 and held it in 1 quarter.
  • CVI Holdings's ESSA Pharma position peaked at $219K in Q1 2018.
  • 9 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2018.

Based on CVI Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.